Free Trial
NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

iSpecimen logo
$1.92 +0.60 (+45.76%)
Closing price 03:59 PM Eastern
Extended Trading
$1.89 -0.03 (-1.82%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iSpecimen Stock (NASDAQ:ISPC)

Key Stats

Today's Range
$1.45
$2.58
50-Day Range
$0.67
$1.94
52-Week Range
$0.64
$8.30
Volume
67.87 million shs
Average Volume
2.66 million shs
Market Capitalization
$10.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iSpecimen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

ISPC MarketRank™: 

iSpecimen scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iSpecimen.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iSpecimen is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iSpecimen is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iSpecimen has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about iSpecimen's valuation and earnings.
  • Percentage of Shares Shorted

    5.49% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently increased by 117.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iSpecimen does not currently pay a dividend.

  • Dividend Growth

    iSpecimen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.49% of the float of iSpecimen has been sold short.
  • Short Interest Ratio / Days to Cover

    iSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iSpecimen has recently increased by 117.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    iSpecimen has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 33 news articles for iSpecimen this week, compared to 1 article on an average week.
  • Search Interest

    26 people have searched for ISPC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    8 people have added iSpecimen to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iSpecimen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 13.62% of the stock of iSpecimen is held by institutions.

  • Read more about iSpecimen's insider trading history.
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISPC Stock News Headlines

iSpecimen (NASDAQ:ISPC) Rating Increased to Sell at Wall Street Zen
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
iSpecimen Completes $1.75M Private Placement Deal
See More Headlines

ISPC Stock Analysis - Frequently Asked Questions

iSpecimen's stock was trading at $2.65 at the beginning of 2025. Since then, ISPC shares have decreased by 16.4% and is now trading at $2.2150.

iSpecimen Inc. (NASDAQ:ISPC) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.80) by $3.38. The company earned $0.71 million during the quarter, compared to analyst estimates of $3.10 million. iSpecimen had a negative trailing twelve-month return on equity of 395.15% and a negative net margin of 172.48%.

iSpecimen (ISPC) raised $20 million in an initial public offering on Thursday, June 17th 2021. The company issued 2,200,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and Braze (BRZE).

Company Calendar

Last Earnings
8/14/2025
Today
9/12/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:ISPC
CIK
1558569
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($9.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.50 million
Net Margins
-172.48%
Pretax Margin
-172.48%
Return on Equity
-395.15%
Return on Assets
-121.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.23
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$9.29 million
Price / Sales
1.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.95 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
5,540,000
Free Float
4,863,000
Market Cap
$10.66 million
Optionable
Not Optionable
Beta
1.61
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ISPC) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners